This site is intended for healthcare professionals only
LoginRegister
Cybercriminals Trick Dr Reddys Finance Team, Divert Rs 2.16 Crore PaymentGame-Changer for HIV: Dr Reddy's, Hetero to Sell Generic Lenacapavir at Rs 3,547 a Year
Sanofi gets approval for 2 rare hematologic diseases medicines in ChinaSanofi Commits USD 625 Million to Sanofi Ventures to Boost Biotech and Digital Health Startups
UP Drug Dept Probes Rs 72 Cr Fake Medicine Racket, Team Sent to Puducherry to Trace Supply ChainSyneos Health Asked to Clarify Phase II Tacrolimus Trial Protocol by CDSCO Panel
Zydus-owned Sentynls Menkes disease drug NDA resubmission accepted by USFDAZydus Lifesciences Gets CDSCO Panel Nod for Bioavailability Study of Antimalarial Candidate ZY-19489
Serum Institute, Vidal Health Partner for Digital Cashless HPV Vaccination ProgrammeSerum Institute, Vidal Health Partner for Digital Cashless HPV Vaccination Programme
Ongoing Sale of Covid-Era Liposomal Amphotericin B Challenged, SC Seeks Response from Top Pharma Firms, DCGISC Quashes Substandard Rabeprazole Case Against Indica Labs, Cites Limitation Bar
NPPA Expands I.V. Fluid Price List, Adds 5 Manufacturers and New PacksNPPA Revises Ceiling Prices of Essential Drugs Including Riboflavin, Dialysis Solutions, Others;...
NIT Rourkela Patents Pumpkin Petal-Silk Protein Formulation for Skin Cancer TreatmentNIT Rourkela Patents Pumpkin Petal-Silk Protein Formulation for Skin Cancer Treatment
CDSCO Panel Asks Astellas Pharma to Update Enzalutamide Label After Phase IV StudyCDSCO Panel Asks Astellas Pharma to Update Enzalutamide Label After Phase IV Study
Lupin receives positive EMA comittee opinion for eye therapy RanluspecLupin gets tentative USFDA nod for HIV drug
Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 crorePfizer to buy obesity drug maker Metsera
Intas PharmaIntas Pharma Told to Revise Phase I, III Pembrolizumab Trial Protocol
X